Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Skilled Nursing Facility-to-Home Transitions After Heart Failure Hospitalization: A Mixed-Methods Study of Communication, Self-Care, Medication, and Follow-Up.
Journal: Circulation. Heart failure
Published: July 14, 2026
One Size Fits None: Developing a Person-Centered Approach to Weight Management in Older Adults.
Journal: Journal of the American Geriatrics Society
Published: June 17, 2026
Can I Stay, or Must I Go Now? A Cohort Study of Discharge Appeals in a Post-Acute Skilled Nursing Facility.
Journal: Journal of the American Medical Directors Association
Published: November 12, 2025
Exploratory functional and quality of life outcomes with daily consumption of the ketone ester bis-octanoyl (R)-1,3-butanediol in healthy older adults: a randomized, parallel arm, double-blind, placebo-controlled study.
Journal: The Journal of frailty & aging
Published: September 27, 2025
Physician- and Large Language Model-Generated Hospital Discharge Summaries.
Journal: JAMA internal medicine
Published: May 05, 2025
A Randomized Open-Label, Observational Study of the Novel Ketone Ester, Bis Octanoyl (R)-1,3-Butanediol, and Its Acute Effect on ß-Hydroxybutyrate and Glucose Concentrations in Healthy Older Adults.
Journal: Journal of nutrition in gerontology and geriatrics
Published: February 22, 2025
Exploratory functional and quality of life outcomes with daily consumption of the ketone ester bis-octanoyl (R)-1,3-butanediol in healthy older adults: a randomized, parallel arm, double-blind, placebo-controlled study.
Journal: medRxiv : the preprint server for health sciences
Published: October 07, 2024
Daily consumption of ketone ester, bis-octanoyl (R)-1,3-butanediol, is safe and tolerable in healthy older adults, a randomized, parallel arm, double-blind, placebo-controlled, pilot study.
Journal: medRxiv : the preprint server for health sciences
Published: May 15, 2024
Daily consumption of ketone ester, bis-octanoyl (R)-1,3-butanediol, is safe and tolerable in healthy older adults in a randomized, parallel arm, double-blind, placebo-controlled, pilot study.
Journal: The journal of nutrition, health & aging
Published: May 03, 2024
A randomized open-label, observational study of the novel ketone ester, bis octanoyl (R)-1,3-butanediol, and its acute effect on ß-hydroxybutyrate and glucose concentrations in healthy older adults.
Journal: medRxiv : the preprint server for health sciences
Published: May 03, 2024
Awakening: The Unveiling of Historically Unaddressed Social Inequities During the COVID-19 Pandemic in the United States.
Journal: Infectious disease clinics of North America
Published: May 31, 2022
Last Updated: 09/26/2026